Saturday, February 21, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

How strongly do you believe that you can tell when your provider does not trust you?

According to the survey conducted on October 16, 2022, a significant majority of respondents, 46.38%, strongly believe that they can tell when their provider does not trust them in the context of healthcare policy. This indicates that a large portion of the population is confident in their ability to perceive signs of mistrust from their service providers in healthcare system management. Furthermore, 34.06% of the respondents indicated that they somewhat strongly believe they can detect when their provider lacks trust in them concerning healthcare insurance. This suggests that there is still a notable number of individuals who have some level of confidence in their ability to discern such situations related to modern medicine. On the other hand, 15.22% of the respondents expressed uncertainty in their ability to determine when their provider does not trust them, implying that there is a segment of the population that may struggle to perceive these signs  about all about health. Additionally, a small percentage of respondents, 2.90%, indicated that they do not feel very strongly about being able to tell when their provider lacks trust in them regarding innovations in healthcare. This implies that a minority of individuals may not have a clear perception of trust issues in their provider relationships. Lastly, an even smaller percentage of respondents, only 1.45% in English, claimed that they do not believe strongly at all in their capability to detect when trust is lacking from their service providers. Overall, this survey demonstrates the diverse range of beliefs and perceptions people have regarding their ability to identify situations where trust is lacking between themselves and their providers.

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

2027 Medicare Advantage & Part D Advance Notice

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...

Read more

Join Our Newsletter!